ANTIBIOTIKA MIT CYCLISCHEM PEPTID

European patent · EP3681875 · In force

Register entry

Publication number
EP3681875
Application number
EP18855877
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Sep 14, 2018
Published
Jul 22, 2020
Granted
Jan 14, 2026
Protection ends at the latest
Sep 13, 2038
Next annual fee due
Sep 30, 2027
IPC classes
C07D 273/00 (2006.01)
A61P 31/00 (2006.01)
Priority
US 201762559244 P 15.09.2017
WO PCT/CN2018/101004 17.08.2018
PCT application
PCT/CN2018/105821 14.09.2018
PCT publication
WO2019/052545 21.03.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. Jan 14, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 14.01.2026

Parties

Holder

F. Hoffmann-La Roche AG

Grenzacherstrasse 124, 4070 Basel

Inventor

HANAN, Emily J.

South San Francisco California 94080, US

CASTANEDO, Georgette

South San Francisco California 94080, US

BRAUN, Marie Gabrielle

South San Francisco California 94080, US

GARLAND, Keira

South San Francisco California 94080, US

SMITH, Peter Andrew

South San Francisco California 94080, US

PASTOR, Richard

South San Francisco California 94080, US

GIBBONS, Paul

South San Francisco California 94080, US

YUEN, Po-Wai

Beijing 100176, CN

CHENG, Yunxing

Beijing 100176, CN

WU, Guosheng

Beijing 100176, CN

FU, Yuhong

Beijing 100176, CN

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.